If you are required to use an Ignition Interlock Device (IID) in California, you already know how unforgiving these machines can be. A single positive breath reading—even as low as 0.02%—can lock your vehicle, trigger a violation report to the DMV or court, extend your IID mandate, or put your driving privileges in jeopardy.

DUI Attorney Matthew Ruff Exposes Flawed Science.

For years, prosecutors and probation officers have treated IID printouts as infallible proof of drinking. However, a groundbreaking 2026 forensic toxicology case report published in the Medico-Legal Journal highlights a critical scientific flaw in breath-testing technology—one that directly impacts the millions of Americans prescribed popular GLP-1 weight-loss and diabetes medications like Wegovy, Ozempic, Mounjaro, and Zepbound.

The 2026 Case Study: Sober for Years, Yet Flagged by the Interlock

Authored by forensic toxicology consultant Aaron Olson, the report examines the case of a 45-year-old woman driving on a restricted license with an Ignition Interlock Device. She had been sober for several years, regularly attended Alcoholics Anonymous meetings, maintained steady employment, and had a spotless compliance record.

Everything changed immediately after her doctor increased her weekly dose of Wegovy (semaglutide) from 1.0 mg to 1.7 mg:

Bullet Day 1 (April 20, 2025): She took her newly escalated 1.7 mg dose of Wegovy.

Bullet Day 2 (April 21, 2025): The next morning before work, she blew into her IID and registered a positive result of 0.034 g/210L, locking her out of her car and forcing her to take an Uber to work.

Bullet Day 4 (April 23, 2025): Two mornings later, she blew another positive result of 0.029 g/210L.

Despite having consumed zero alcohol, she faced court action over the disputed readings.

The Science: How GLP-1 Medications Fool Breathalyzers

To understand how someone who hasn’t touched a drop of alcohol can fail an IID test, you have to look at how the human body processes fat—and how ignition interlock sensors actually work.

1. Appetite Suppression Triggers Ketosis: Escalating a GLP-1 medication dose dramatically suppresses appetite and reduces caloric intake. When your body doesn’t get enough calories from food, it shifts its metabolism to burn stored fat for energy.

2. Fat Metabolism Produces Acetone: Breaking down fatty acids generates ketone bodies, including acetone.

3. The Body Converts Acetone into Isopropanol: Through a natural enzyme process (involving alcohol dehydrogenase), your body can chemically reduce endogenous acetone into isopropanol (isopropyl alcohol), which is then exhaled through your breath.

4. Fuel-Cell Sensors Cannot Tell the Difference: Unlike sophisticated hospital or crime-lab gas chromatography equipment, standard IIDs rely on electrochemical fuel-cell sensors. While acetone itself generally does not trigger these sensors, isopropanol does. Because the fuel cell cannot distinguish between ethanol (drinking alcohol) and isopropanol produced by your own metabolism, the device registers a false-positive BAC reading.

Not an Isolated Phenomenon

As Olson notes in his paper, this biochemical chain reaction is well-documented in forensic science. Previous peer-reviewed studies have recorded false-positive breath alcohol readings in individuals following strict ketogenic diets (producing apparent BACs between 0.01% and 0.02%) as well as in patients experiencing diabetic ketoacidosis (producing readings as high as 0.048%).

What makes this 2026 report so significant for DUI defense is that it identifies GLP-1 dose escalation as a brand-new, widespread trigger for this exact same false-positive mechanism.

What This Means for California Drivers on an IID

With millions of drivers now taking GLP-1 receptor agonists, wrongful IID violations are bound to rise—especially during the weeks following a dosage increase. In California, where the DMV and criminal courts impose strict zero-tolerance thresholds (often 0.01% or 0.02%) on restricted drivers, an unexplained lockout can quickly spiral into a license suspension or probation violation.

If you use a GLP-1 medication and experience a disputed IID reading:

Bullet Document your prescription history immediately: Keep records showing the exact dates your medication was prescribed and when your dosage was increased.

Bullet Get an independent blood or EtG test if possible: Laboratory testing can distinguish between actual ethanol consumption and metabolic byproducts.

Bullet Do not simply plead guilty to a violation: Courts and DMV hearing officers rarely understand the chemistry behind fuel-cell cross-reactivity unless an experienced DUI defense attorney presents the science.

Accused of an IID Violation or DUI in Southern California? Call Matthew Ruff

Breath-testing machines are not infallible, and science is constantly uncovering new ways biological and medical factors skew their results. For nearly 30 years, Torrance and Redondo Beach DUI Attorney Matthew J. Ruff has been at the forefront of challenging faulty breathalyzer and blood evidence in California courts and DMV hearings. Having previously exposed how Ozempic and other Glp-1 drugs can falsely convict innocent people of DUI, Matthew is committed to being the scientific evidence “truth teller” in drunk driving cases.

If you are facing an Ignition Interlock violation, a DMV license suspension, or a DUI charge in Los Angeles, Torrance, Long Beach, or anywhere in Southern California, do not let a flawed machine cost you your license. Call or text Matthew Ruff directly at 310-686-1533 or call 310-527-4100 for a free, confidential case evaluation.